Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Genitourinary 2Gastrointestinal 2

Conditions

Uterine Cervical Neoplasms 3Vulvar Neoplasms 2Vaginal Neoplasms 2Stomach Neoplasms 2Penile Neoplasms 2Oropharyngeal Neoplasms 2Melanoma 2Anus Neoplasms 2Neoplasm Metastasis 1Lung Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Breast Neoplasms 1

Interventions

Radiotherapy 7Brachytherapy 6Surveys and Questionnaires 4Magnetic Resonance Spectroscopy 4durvalumab 3Radiosurgery 3Methods 3tremelimumab 2aldesleukin 2Topotecan 2Radiation 2Palliative Care 2Paclitaxel 2Immunoglobulin G 2Gemcitabine 2Early Intervention, Educational 2Disulfides 2Dehydroepiandrosterone 2Counseling 2Capecitabine 2Bevacizumab 2Behavior Therapy 2Adoptive Transfer 2zimberelimab 1temsirolimus 1talazoparib 1rocakinogene sifuplasmid 1liposomal doxorubicin 1fludarabine phosphate 1dostarlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Vaginal Neoplasms × Adoptive Transfer × Clear all
NCT05639972 2026-02-27

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Rutgers, The State University of New Jersey

Phase 1/2 Recruiting
15 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05686226 2026-02-27

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Rutgers, The State University of New Jersey

Phase 2 Recruiting
20 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡